Interleukin-6 and C-reactive protein in metastatic renal cell carcinoma [1]

Journal of Clinical Oncology

Volumn 23, Issue 5, 2005, Pages 1044-

  Altundag, Ozden ^a   Altundag, Kadri ^a   Gunduz, Esra ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR MARKER;

CYTOKINE PRODUCTION; HUMAN; IMMUNOGENICITY; INFLAMMATION; KIDNEY CARCINOMA; KIDNEY METASTASIS; LETTER; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; TRANSCRIPTION REGULATION; BLOOD; KIDNEY TUMOR; METASTASIS; NOTE; PATHOLOGY;

C-REACTIVE PROTEIN; CARCINOMA, RENAL CELL; HUMANS; INTERLEUKIN-6; KIDNEY NEOPLASMS; PARANEOPLASTIC SYNDROMES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 14644435101     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.155     Document Type: Letter

References (2)

1. Negrier S, Perol D, Menetrier-Caux C, et al: Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6-from the Groupe Francais d'Immunotherapie. J Clin Oncol 22:2371-2378, 2004
2. Blay J-Y, Rossi J-F, Wijdenes J, et al: Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer 72:424-430, 1997